Stock Analysis
Data Source: SEC EDGAR 13F
Updated Hourly

Outset Med Inc (OM)

93 + Investors. Track Smart Money conviction in OM. See who's accumulating, reducing, or initiating positions.

Current Price
-- USD
Analyst Target
-- (0 analysts)
Upside
0.00%
Net Flow Q/Q
↓ -3
Streak
2Q ▼
Buyers last Q
55%

Smart Money Signals — OM

Based on 94 hedge funds · latest filing: 2026 Q1 · updated quarterly

📉

Selling streak — 2 quarters in a row

last 6Q
For 2 consecutive quarters, more hedge funds reduced or closed their OM positions than added to them. Sustained institutional selling is a meaningful warning sign — these are professionals with deep research teams collectively deciding to exit.
🔻

Below peak — only 64% of 3.0Y high

64% of all-time peak
Only 94 funds hold OM today versus a peak of 148 funds at 2023 Q2 — just 64% of the maximum. Low institutional ownership can mean the stock is out of favor, but it also means there's a large pool of potential buyers if sentiment turns.
🚀

Fast accumulation — +49% more funds vs a year ago

fund count last 6Q
+31 new funds entered over the past year (+49% YoY). That's a rapid rush of institutional money. Fast accumulation often signals a major thesis — but it also means the stock could fall quickly if that thesis breaks.
🟡

Slight buying edge — 55% buying

58 buying47 selling
Last quarter: 58 funds bought or added vs 47 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.
➡️

Steady new buyers — ~22 new funds per quarter

new funds entering per quarter
Funds opening this position for the first time: 40 → 18 → 20 → 22. A stable flow of new institutional buyers suggests ongoing interest without signs of either acceleration or slowdown.
🔒

54% of holders stayed for 2+ years

■ 54% conviction (2yr+) ■ 18% medium ■ 28% new
51 out of 94 hedge funds have held OM for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.
📊

Peak discovery — momentum slowing

19 → 40 → 18 → 20 → 22 new funds/Q
New funds entering each quarter: 40 → 18 → 20 → 22. OM is well-known in the hedge fund world, but fresh entries are gradually declining. The explosive phase of institutional discovery is likely behind us.
🏛️

Veteran-anchored — 65% veterans vs 24% newcomers

■ 65% veterans ■ 10% 1-2yr ■ 24% new
Entry-cohort mix of 98 holders: 64 (65%) are 2+ year veterans, 10 entered 1–2 years ago, and 24 (24%) joined within the past year. A veteran-weighted cap table skews toward institutional memory over fresh momentum.
🏆

Elite ownership — 43% AUM from top-100 funds

43% from top-100 AUM funds
26 of 93 holders are among the 100 largest funds by AUM, controlling 43% of total institutional value in OM. When the biggest players dominate the cap table, it signifies deep institutional support — since mega-funds deploy the most rigorous due diligence and capital.
2.1
out of 10
Low Exit Risk
Exit risk score 2.1/10 — low institutional crowding. Ownership is below peak levels, holder base is relatively sticky, and buying momentum is positive.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Institutional Sentiment Summary — OM

In 2026 Q1, 58 hedge funds were net buyers of OM (22 opened a new position, 36 added to an existing one), while 47 reduced or exited (22 trimmed, 25 sold completely) — a 55% buyer ratio, indicating a slight buying edge. Net selling has persisted for two consecutive quarters. 43% of total institutional value in OM is held by top-100 AUM funds, reflecting elite-tier ownership quality. Net fund flow last quarter: -3 funds (more exits than new entries). Total institutional holders: 94.

Hedge Fund Ownership: OM

How many hedge funds hold OM — quarterly history vs. share price
Quarterly hedge fund ownership of OM vs. share price

Market Analysis: OM

Analyst Price Targets

Avg. Price Target
--

Analyst Recommendations

Stock Performance

Real-time

Company Profile: OM

-- --

Institutional ownership data sourced from SEC EDGAR Form 13F-HR filings.

Is It Too Late to Buy Outset Med Inc (OM) Based on Hedge Fund 13F Filings?

Signal Freshness measures how much OM has moved relative to its sector benchmark (XLV) since the 2026 Q1 13F filing. A stock that has barely outrun its sector is still a relatively fresh entry point — the fund's thesis has not yet been priced in by the broader market.

Since Quarter End March 31, 2026 · 87d ago
OM
+25.5%
XLV
+9.6%

OM outperformed XLV by +15.9% since March 31, 2026.

Since 13F Filing Date May 15, 2026 · 42d ago
OM
+33.1%
XLV
+10.7%

Since the filing became public, OM outperformed XLV by +22.4% .

Interpretation: The stock has meaningfully outrun its sector. The trade has partially played out; entry is at a premium to the fund's implied reference. Learn more →

Smart Money Signal ?
Limited Smart Money Interest

No strong consensus or elite conviction detected among institutional holders.

13 top-rated funds 1 high-conviction
Consensus
5.0
/ 10
breadth
×
Elite
2.0
/ 10
conviction
Hedge Fund Positioning: OM
93 + Investors

Track Smart Money conviction in OM. See who's accumulating, reducing, or initiating positions.

Metric All 13F Filers (2026 Q1) Prior (2025 Q4) Change
Funds Holding 93 97 -4.12%
13F Shares 16M 16M -1.01%
Total Value $60M $58M 3.15%
New Positions 21 20 +1
Increased Positions 36 33 +3
Closed Positions 25 23 +2
Reduced Positions 21 24 -3
Total Calls 2 0 100%
Total Puts 3 2 50.0%
PUT/CALL Ratio 1.5 0.0 Bearish

Statistics: OM

View More

Valuation Measures Data as of: --

Market Cap --
Enterprise Value --
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales (ttm) --
Price/Book (mrq) --
Enterprise Value/Revenue --
Enterprise Value/EBITDA --
Beta (5Y Monthly) --
Short Ratio (Days to Cover) --
Short % of Float --

Financial Highlights

Profitability
Profit Margin --
Return on Assets (ttm) --
Return on Equity (ttm) --
Income Statement & Cash Flow
Revenue (ttm) --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Total Cash (mrq) --
Total Debt/Equity (mrq) --
Levered Free Cash Flow (ttm) --

Institutional Holders (2026 Q1)

93 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in OM. Verified SEC 13F-HR filings.

QUARTER:
Top 25 OM holders by conviction (% of portfolio weight) — 2026 Q1 · Source: SEC Form 13F
# Investor % of Portfolio Shares Mkt Value
1 BML Capital Management, LLC 4.69% 1,902,201 $7.3M
2 Pura Vida Investments, LLC 2.15% 83,333 $320K
3 Birchview Capital, LP 0.22% 98,882 $380K
4 PFM Health Sciences, LP 0.21% 594,630 $2.3M
5 Catalio Capital Management, LP 0.09% 118,279 $454K
6 Perceptive Advisors LLC 0.06% 833,333 $3.2M
7 R Squared Ltd 0.04% 17,052 $65K
8 XTX Topco Ltd 0.01% 142,450 $547K
9 Stratos Wealth Partners, LTD. 0.01% 200,546 $770K
10 Gmt Capital Corp 0.01% 42,421 $163K
11 Woodline Partners LP 0.00% 292,437 $1.1M
12 Ensign Peak Advisors, Inc 0.00% 526,585 $2.0M
13 Essential Partners LLC 0.00% 2,505 $10K
14 Engineers Gate Manager LP 0.00% 66,869 $257K
15 Assenagon Asset Management S.A. 0.00% 504,093 $1.9M
16 Centiva Capital, LP 0.00% 50,719 $195K
17 Aqr Capital Management LLC 0.00% 808,285 $3.1M
18 Renaissance Technologies LLC 0.00% 222,075 $853K
19 Tower Research Capital LLC (TRC) 0.00% 7,721 $30K
20 Ieq Capital, LLC 0.00% 39,737 $153K
21 Fmr LLC 0.00% 2,741,673 $10.5M
22 Bank of America Corp /de/ 0.00% 949,397 $3.6M
23 Cwm, LLC 0.00% 22,139 $85K
24 Ameritas Investment Partners, Inc. 0.00% 1,809 $7K
25 Citadel Advisors LLC 0.00% 265,700 $1.0M
Investor Ownership
History 		% of Portfolio Prev % Rank Conviction Avg Buy Price 13F Score™ 3Y / 7Y Sell Timing Shares Mkt Value Change Change % Source Quarter Filed

Frequently Asked Questions — Outset Med Inc (OM)

What does the Smart Money Trend signal show for OM?

Selling streak — 2 quarters in a row: For 2 consecutive quarters, more hedge funds reduced or closed their OM positions than added to them. Sustained institutional selling is a meaningful warning sign — these are professionals with deep research teams collectively deciding to exit.

What is the institutional breadth score for OM?

Slight buying edge — 55% buying: Last quarter: 58 funds bought or added vs 47 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.

What is the fund quality score for OM holders?

Elite ownership — 43% AUM from top-100 funds: 26 of 93 holders are among the 100 largest funds by AUM, controlling 43% of total institutional value in OM. When the biggest players dominate the cap table, it signifies deep institutional support — since mega-funds deploy the most rigorous due diligence and capital.

How long have hedge funds held OM?

54% of holders stayed for 2+ years: 51 out of 94 hedge funds have held OM for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.

Is it too late to buy Outset Med Inc (OM) following the 2026 Q1 hedge fund 13F filings?

As of today, OM has moved +33.1% since the 2026 Q1 13F filing date (May 15, 2026), compared to +10.7% for the XLV sector ETF — an outperformance of +22.4%. Since the quarter end (March 31, 2026), OM has gained +25.5% vs +9.6% for XLV. The stock has meaningfully outrun its sector. The trade has partially played out; entry is at a premium to the fund's implied reference.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Disclaimer: The information on this page is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Institutional holdings data is sourced from SEC Form 13F filings and reflects positions as of the filing date. Past performance of any fund or portfolio is not indicative of future results. 13Foresight is not a registered investment adviser. Always conduct your own due diligence before making investment decisions.

Full history →